Creatd, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Creatd, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $4.80M | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | $4.30M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $1.21M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $453.0K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $80.9K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $95.7K | Apr 1, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $95.7K | May 17, 2018 |
| FY2017 | Dec 31, 2016 | $223.9K | May 17, 2018 |
| FY2016 | Dec 31, 2015 | $767.5K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $11.4K | Apr 14, 2016 |
| FY2013 | Dec 31, 2013 | $13.8K | Apr 4, 2014 |
| FY2013 | Dec 31, 2012 | $19.2K | Apr 4, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($1.31M) | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | ($1.00M) | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | ($282.2K) | Apr 6, 2022 |
| FY2019 | Dec 31, 2019 | $453.0K | Mar 30, 2020 |
| FY2019 | Dec 31, 2018 | $80.9K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $95.7K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $180.6K | May 17, 2018 |
| FY2016 | Dec 31, 2015 | $584.0K | Mar 31, 2017 |
| FY2013 | Dec 31, 2013 | $12.2K | Apr 4, 2014 |
| FY2013 | Dec 31, 2012 | $17.3K | Apr 4, 2014 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($32.29M) | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | ($37.29M) | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | ($24.21M) | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | ($8.04M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($12.01M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($8.75M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($7.39M) | May 17, 2018 |
| FY2016 | Dec 31, 2015 | ($3.34M) | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | ($378.0K) | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($80.2K) | Mar 19, 2015 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($29.03M) | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | ($33.37M) | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | ($16.28M) | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | ($7.22M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($5.69M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($5.56M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($3.69M) | May 17, 2018 |
| FY2016 | Dec 31, 2015 | ($2.85M) | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | ($306.4K) | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($69.1K) | Mar 19, 2015 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $951.4K | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | $983.5K | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $257.4K | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $1.13M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $636.2K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $590.2K | Apr 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($16.81M) | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | ($20.52M) | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | ($7.34M) | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | ($5.96M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($4.97M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($3.85M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($2.52M) | May 17, 2018 |
| FY2016 | Dec 31, 2015 | ($2.29M) | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | ($266.6K) | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($118.3K) | Mar 19, 2015 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $212.2K | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | $95.9K | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $45.0K | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $27.9K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $27.6K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $14.7K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $44.0K | May 17, 2018 |
| FY2016 | Dec 31, 2015 | $69.2K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $327.2K | Apr 14, 2016 |
| FY2015 | Sep 17, 2014 | $83.4K | Apr 14, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $4.82M | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | $9.17M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $10.78M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $2.57M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $208.9K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $177.4K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $378.1K | May 17, 2018 |
| FY2016 | Dec 31, 2015 | $609.5K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $1.36M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $1.56M | Mar 19, 2015 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $17.32M | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | $5.49M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $5.34M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $11.13M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.70M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($472.4K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.55M | May 17, 2018 |
| FY2016 | Dec 31, 2015 | $969.9K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $90.4K | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $7.5K | Mar 19, 2015 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($11.75M) | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | $1.81M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $5.45M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | ($8.56M) | Mar 31, 2021 |
| FY2020 | Dec 31, 2018 | ($2.49M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | ($7.37M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | ($2.91M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | ($360.5K) | May 17, 2018 |
| FY2016 | Dec 31, 2014 | ($1.45M) | Mar 31, 2017 |
| FY2015 | Dec 31, 2013 | $1.55M | Apr 14, 2016 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $46.5K | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | $1.37M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $1.04M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $1.04M | Mar 31, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($146.14M) | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | ($109.63M) | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | ($71.93M) | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | ($44.58M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($36.55M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($21.78M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($13.28M) | May 17, 2018 |
| FY2016 | Dec 31, 2015 | ($5.71M) | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | ($691.9K) | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($313.9K) | Mar 19, 2015 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $706.2K | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | $3.79M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $7.91M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $11.6K | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $111.1K | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $174.5K | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $438.6K | May 17, 2018 |
| FY2016 | Dec 31, 2014 | $125.1K | Mar 31, 2017 |
| FY2015 | Dec 31, 2013 | $1.48M | Apr 14, 2016 |
| FY2013 | Dec 31, 2012 | $447 | Apr 4, 2014 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2018 | $123.5K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.51M | Apr 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | (1) | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | (2) | Apr 19, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | (1) | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | (3) | Apr 19, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 38.97M | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | 16.69M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | 8.73M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | 3.01M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 6.45M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 39.52M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 33.89M | May 17, 2018 |
| FY2016 | Dec 31, 2015 | 28.50M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | 1.46M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | 7.99M | Mar 19, 2015 |